Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 18 05 2018
accepted: 17 12 2019
entrez: 4 2 2020
pubmed: 6 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

Risk of the development of multiple sclerosis (MS) is known to be increased in individuals bearing distinct class II human leukocyte antigen (HLA) variants, whereas some of them may have a protective effect. Here we analyzed distribution of a highly polymorphous HLA-

Identifiants

pubmed: 32010139
doi: 10.3389/fimmu.2019.03088
pmc: PMC6978714
doi:

Substances chimiques

Amino Acids 0
Antigens 0
Epitopes 0
HLA-DRB1 Chains 0
Myelin Basic Protein 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3088

Informations de copyright

Copyright © 2020 Mamedov, Vorobyeva, Filimonova, Zakharova, Kiselev, Bashinskaya, Baulina, Boyko, Favorov, Kulakova, Ziganshin, Smirnov, Poroshina, Shilovskiy, Khaitov, Sykulev, Favorova, Vlassov, Gabibov and Belogurov.

Références

Autoimmun Rev. 2011 Jun;10(8):474-81
pubmed: 21440682
Immunity. 1998 Nov;9(5):699-709
pubmed: 9846491
Hum Mol Genet. 2006 Sep 15;15(18):2813-24
pubmed: 16905561
PLoS One. 2012;7(8):e41466
pubmed: 22870225
Immunol Rev. 2012 Nov;250(1):32-48
pubmed: 23046121
Science. 1988 May 20;240(4855):1003-9
pubmed: 3368786
Nature. 2017 May 11;545(7653):243-247
pubmed: 28467828
J Biol Chem. 2014 Aug 22;289(34):23449-64
pubmed: 25002586
Nat Rev Immunol. 2015 Apr;15(4):203-16
pubmed: 25720354
Rapid Commun Mass Spectrom. 2003;17(20):2337-42
pubmed: 14558135
EMBO J. 2011 Mar 16;30(6):1137-48
pubmed: 21297580
Immunol Rev. 2002 Nov;189:136-51
pubmed: 12445271
Annu Rev Immunol. 1994;12:259-93
pubmed: 8011283
Mol Biol (Mosk). 1998 Mar-Apr;32(2):291-6
pubmed: 9608945
Annu Rev Immunol. 1991;9:493-525
pubmed: 1910687
Immunity. 1995 Aug;3(2):197-205
pubmed: 7648393
J Immunol. 2015 Jul 15;195(2):706-16
pubmed: 26062997
EMBO J. 2005 Sep 7;24(17):2968-79
pubmed: 16079912
J Immunol. 2008 Jan 15;180(2):1258-67
pubmed: 18178866
Nature. 1994 Mar 17;368(6468):215-21
pubmed: 8145819
Nat Rev Immunol. 2003 Dec;3(12):973-83
pubmed: 14647479
Mol Biosyst. 2014 Aug;10(8):2043-54
pubmed: 24853027
Lancet Neurol. 2014 Jul;13(7):700-9
pubmed: 24852507
Nat Immunol. 2005 May;6(5):490-6
pubmed: 15821740
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
J Mol Biol. 2000 Nov 24;304(2):177-88
pubmed: 11080454
Cell. 2012 Dec 21;151(7):1557-68
pubmed: 23260142
Diabetes. 2019 Apr;68(4):787-795
pubmed: 30626607
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9900-4
pubmed: 7568241
Lancet Neurol. 2015 Apr;14(4):406-19
pubmed: 25792099
Sci Transl Med. 2015 Jul 15;7(296):296ra112
pubmed: 26180102
J Immunol. 2008 Jul 1;181(1):795-807
pubmed: 18566446
Bull Exp Biol Med. 2016 Jul;161(3):442-446
pubmed: 27520960
J Exp Med. 1998 Oct 19;188(8):1511-20
pubmed: 9782128
J Control Release. 2015 Sep 10;213:45-56
pubmed: 26134071
Mult Scler. 2018 Jan;24(1):75-79
pubmed: 29307290
Genome Med. 2009 Nov 06;1(11):105
pubmed: 19895714
J Immunol. 1998 May 1;160(9):4386-97
pubmed: 9574543
PLoS One. 2013;8(3):e59711
pubmed: 23555757
Oncoimmunology. 2017 Feb 6;6(2):e1171447
pubmed: 28344859
Nat Immunol. 2011 Jan;12(1):54-61
pubmed: 21131964
Nature. 1995 Nov 30;378(6556):457-62
pubmed: 7477400
Methods Mol Biol. 2009;499:1-8
pubmed: 19152033
Science. 1996 Oct 25;274(5287):618-20
pubmed: 8849454

Auteurs

Azad Mamedov (A)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Nadezhda Vorobyeva (N)

Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.

Ioanna Filimonova (I)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Maria Zakharova (M)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Pirogov Russian National Research Medical University, Moscow, Russia.

Ivan Kiselev (I)

Pirogov Russian National Research Medical University, Moscow, Russia.

Vitalina Bashinskaya (V)

Pirogov Russian National Research Medical University, Moscow, Russia.

Natalia Baulina (N)

Pirogov Russian National Research Medical University, Moscow, Russia.

Alexey Boyko (A)

Pirogov Russian National Research Medical University, Moscow, Russia.
Neuroimmunological Department of the Federal Center of Cerebrovascular Diseases and Stroke, Moscow, Russia.

Alexander Favorov (A)

Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD, United States.
Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.

Olga Kulakova (O)

Pirogov Russian National Research Medical University, Moscow, Russia.

Rustam Ziganshin (R)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Ivan Smirnov (I)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Institute of Fundamental Medicine and Biology, Kazan (Volga) Federal University, Kazan, Russia.

Alina Poroshina (A)

National Research Center Institute of Immunology FMBA of Russia, Moscow, Russia.

Igor Shilovskiy (I)

National Research Center Institute of Immunology FMBA of Russia, Moscow, Russia.

Musa Khaitov (M)

National Research Center Institute of Immunology FMBA of Russia, Moscow, Russia.

Yuri Sykulev (Y)

Department of Microbiology, Thomas Jefferson University, Philadelphia, PA, United States.

Olga Favorova (O)

Pirogov Russian National Research Medical University, Moscow, Russia.

Valentin Vlassov (V)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia.

Alexander Gabibov (A)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Department of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.

Alexey Belogurov (A)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Department of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH